DOPAMINE D-2 AND D-3 RECEPTOR PREFERRING ANTAGONISTS DIFFERENTIALLY AFFECT STRIATAL DOPAMINE RELEASE AND METABOLISM IN CONSCIOUS RATS

被引:38
作者
GAINETDINOV, RR
GREKHOVA, TV
SOTNIKOVA, TD
RAYEVSKY, KS
机构
[1] Laboratory of Neurochemical Pharmacology, Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow, 125315
关键词
DOPAMINE RELEASE; DOPAMINE METABOLISM; DOPAMINE D-2 RECEPTOR; DOPAMINE D-3 RECEPTOR; NEUROLEPTIC; MICRODIALYSIS;
D O I
10.1016/0014-2999(94)90125-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Classical neuroleptic drugs with high affinity for dopamine D-2 receptors in comparison to D-3 ones (haloperidol, thioproperazine and spiperone) administered i.p. acutely (0.2, 0.2 and 0.07 mg/kg, respectively) induced a pronounced increase in the extracellular level of 3,4-dihydroxyphenylacetic acid (DOPAC) and only a modest rise in that of dopamine in the dorsal striatum of conscious rats studied by transcerebral microdialysis. Atypical neuroleptics, clozapine and thioridazine (both 20 mg/kg), demonstrating relatively higher affinity for dopamine D, receptor than typical ones, as well as the dopamine D, receptor and autoreceptor preferring an tagonists, cis-(+)-(1S,2 R)-5-methoxy-1-methyl-2-(di-n-propylamino)tetralin HCl (( +)-UH232) and cis-(+)-(1S,2R)-5-methoxy-1-methyl-2-(n-propylamino)tetralin HCl ((+)-AJ76) (both 14 mg/kg), were equally effective or even more potent in increasing dopamine release than DOPAC. It is concluded that the dopamine D-2/D-3 receptor relative potencies of typical and atypical neuroleptics appear to correspond to their ability to affect preferentially dopamine metabolism or release in rat dorsal striatum in vivo.
引用
收藏
页码:327 / 331
页数:5
相关论文
共 15 条
  • [1] Booze R. M., 1993, Society for Neuroscience Abstracts, V19, P76
  • [2] CARLSSON A, 1991, BIOL PSYCHIAT, V2, P687
  • [3] Damsma G., 1993, Society for Neuroscience Abstracts, V19, P77
  • [4] DICHIARA G, 1985, J PHARMACOL EXP THER, V235, P487
  • [5] STEREOISOMERS OF THE ATYPICAL NEUROLEPTIC CARBIDINE MODULATE STRIATAL DOPAMINE RELEASE IN AWAKE RATS
    GUINETDINOV, RR
    BOGDANOV, MB
    POGORELOV, VM
    KUDRIN, VS
    RAYEVSKY, KS
    [J]. NEUROPHARMACOLOGY, 1991, 30 (11) : 1251 - 1254
  • [6] REMOXIPRIDE AND RACLOPRIDE DIFFER FROM METOCLOPRAMIDE BY THEIR EFFECTS ON STRIATAL DOPAMINE RELEASE AND BIOSYNTHESIS IN RATS
    GUINETDINOV, RR
    BOGDANOV, MB
    KUDRIN, VS
    RAYEVSKY, KS
    [J]. NEUROPHARMACOLOGY, 1994, 33 (02) : 215 - 219
  • [7] IMPERATO A, 1989, PSYCHOPHARMACOL BULL, V25, P383
  • [8] IDENTIFICATION, CHARACTERIZATION, AND LOCALIZATION OF THE DOPAMINE-D3 RECEPTOR IN RAT-BRAIN USING 7-[H-3]HYDROXY-N,N-DI-NORMAL-PROPYL-2-AMINOTETRALIN
    LEVESQUE, D
    DIAZ, J
    PILON, C
    MARTRES, MP
    GIROS, B
    SOUIL, E
    SCHOTT, D
    MORGAT, JL
    SCHWARTZ, JC
    SOKOLOFF, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) : 8155 - 8159
  • [9] Paxinos G., 2007, RAT BRAIN STEROTAXIC
  • [10] THE REGULATION OF DOPAMINE RELEASE FROM NIGROSTRIATAL NEURONS IN CONSCIOUS RATS - THE ROLE OF SOMATODENDRITIC AUTORECEPTORS
    SANTIAGO, M
    WESTERINK, BHC
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (01) : 79 - 85